Numerous studies have shown that ELAVL1 is overexpressed in a range of cancers, including lung, liver, and pancreatic cancers, where it promotes tumorigenesis by stabilizing the mRNAs of cancer-related genes. This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.